Die Thüringen-Kliniken „Georgius Agricola“ sind ein Krankenhaus mit Standorten in Saalfeld/Saale, Rudolstadt und Pößneck. Die Kliniken befinden sich in kommunaler Trägerschaft des Landkreises Saalfeld-Rudolstadt und sind Akademisches Lehrkrankenhaus des Universitätsklinikums Jena.

During the past decade, Thüringen Kliniken "Georgius Agricola" conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thüringen Kliniken "Georgius Agricola"" #1 sponsor was "AGO Research GmbH" with 2 trials, followed by "AGO Study Group" with 1 trials sponsored, "Center for Sepsis Control and Care, Germany" with 1 trials sponsored, "Medtronic - MITG" with 1 trials sponsored and "University of Witten/Herdecke" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thüringen Kliniken "Georgius Agricola"" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "KCI Europe Holding B.V." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Thüringen Kliniken "Georgius Agricola"" are "Recurrent Ovarian Carcinoma" (2 trials), "Abdominal Wound Healing Disorder" (1 trials), "Abdominal Wound Healing Impairment" (1 trials), "Acute Postsurgical Subcutaneous Wound" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Thüringen Kliniken "Georgius Agricola"" in a lesser frequency.

Most popular intervention types in "Thüringen Kliniken "Georgius Agricola"" are "Drug" (3 trials), "Behavioral" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab" (1 trials) and "Change Management" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thüringen Kliniken "Georgius Agricola"" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Thüringen Kliniken "Georgius Agricola"". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Thüringen Kliniken "Georgius Agricola", undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Thüringen Kliniken "Georgius Agricola", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".